{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T21:56:30Z","timestamp":1795211790490,"version":"4.10.3"},"reference-count":33,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,2,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Hematopoietic cell transplantation\u2013associated thrombotic microangiopathy (TMA) is a complication associated with higher nonrelapse mortality (NRM) in patients who undergo allogeneic transplant (HCT). Current classification criteria are not generally agreed on or validated, and the presence of confounding factors after transplant contribute to underdiagnosis or delayed diagnosis of TMA. We studied risk factors, incidence, and biomarkers of TMA in 119 adult allogeneic HCT recipients. Twenty-seven patients developed a clinically actionable phenotype of TMA (CA-TMA) and the incidence of CA-TMA was 22% by day 180. Among the 27 patients who developed CA-TMA, 10 developed it before the onset of acute graft-versus-host disease (aGVHD), and 17 patients developed it after the onset of aGVHD. We report for the first time that age &amp;gt;50 years, BK hemorrhagic cystitis, and other viral infections (CMV, HHV-6, or adenovirus) are risk factors for adult CA-TMA. Even after adjustment for aGVHD, CA-TMA was independently associated with significantly higher NRM. These data illustrate relationships between CA-TMA and aGVHD, describe new risk factors for CA-TMA and emphasizes the need to develop validated set of criteria for timely diagnosis.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021004933","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T16:30:01Z","timestamp":1645461001000},"page":"1342-1349","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":19,"title":["Acute GVHD, BK virus hemorrhagic cystitis and age are risk factors for transplant-associated thrombotic microangiopathy in adults"],"prefix":"10.1182","volume":"6","author":[{"given":"Sumithira","family":"Vasu","sequence":"first","affiliation":[{"name":"Division of Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Bostic","sequence":"additional","affiliation":[{"name":"Division of Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhong","family":"Zhao","sequence":"additional","affiliation":[{"name":"Division of Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1302-7099","authenticated-orcid":false,"given":"Nidhi","family":"Sharma","sequence":"additional","affiliation":[{"name":"Division of Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Puto","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Ohio State University, Columbus, OH; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Knight","sequence":"additional","affiliation":[{"name":"Division of Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Scott","sequence":"additional","affiliation":[{"name":"Division of Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalyn","family":"Guzman","sequence":"additional","affiliation":[{"name":"Division of Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Kromer","sequence":"additional","affiliation":[{"name":"Division of Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Tackett","sequence":"additional","affiliation":[{"name":"Division of Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Lind","sequence":"additional","affiliation":[{"name":"Division of Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Knill","sequence":"additional","affiliation":[{"name":"Division of Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Watson","sequence":"additional","affiliation":[{"name":"Division of Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8845-1046","authenticated-orcid":false,"given":"Sarah","family":"Wall","sequence":"additional","affiliation":[{"name":"Division of Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0003-0130","authenticated-orcid":false,"given":"Ayman","family":"Saad","sequence":"additional","affiliation":[{"name":"Division of Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Choe","sequence":"additional","affiliation":[{"name":"Division of Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1898-9836","authenticated-orcid":false,"given":"Karilyn","family":"Larkin","sequence":"additional","affiliation":[{"name":"Division of Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Brammer","sequence":"additional","affiliation":[{"name":"Division of Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4335-2554","authenticated-orcid":false,"given":"Samantha","family":"Jaglowski","sequence":"additional","affiliation":[{"name":"Division of Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Penza","sequence":"additional","affiliation":[{"name":"Division of Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella M.","family":"Davies","sequence":"additional","affiliation":[{"name":"Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spero","family":"Cataland","sequence":"additional","affiliation":[{"name":"Division of Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,2,21]]},"reference":[{"issue":"11","key":"2022022116204527400_B1","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/sj.bmt.1705160","article-title":"Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants","volume":"36","author":"Martinez","year":"2005","journal-title":"Bone Marrow Transplant."},{"issue":"12","key":"2022022116204527400_B2","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2013-05-501445","article-title":"Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic angiopathy [plenary paper]","volume":"122","author":"Jodele","year":"2013","journal-title":"Blood."},{"issue":"4","key":"2022022116204527400_B3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","article-title":"Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults","volume":"124","author":"Jodele","year":"2014","journal-title":"Blood."},{"issue":"11","key":"2022022116204527400_B4","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.bbmt.2015.06.016","article-title":"Histologic features of intestinal thrombotic microangiopathy in pediatric and young adult patients after hematopoietic stem cell transplantation","volume":"21","author":"El-Bietar","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"issue":"20","key":"2022022116204527400_B5","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1182\/bloodadvances.2018020321","article-title":"Complement-mediated thrombotic microangiopathy as a link between endothelial damage and steroid-refractory GVHD","volume":"2","author":"Wall","year":"2018","journal-title":"Blood Adv."},{"issue":"11","key":"2022022116204527400_B6","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.bbmt.2013.07.017","article-title":"Pulmonary hypertension after hematopoietic stem cell transplantation","volume":"19","author":"Dandoy","year":"2013","journal-title":"Biol Blood Marrow Transplant."},{"issue":"12","key":"2022022116204527400_B7","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.bbmt.2020.09.018","article-title":"Thrombotic Microangiopathy after post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis","volume":"26","author":"Imus","year":"2020","journal-title":"Biol Blood Marrow Transplant."},{"issue":"11","key":"2022022116204527400_B8","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1111\/trf.14263","article-title":"Impact of treatment and outcomes for patients with posttransplant drug-associated thrombotic microangiopathy","volume":"57","author":"Epperla","year":"2017","journal-title":"Transfusion."},{"issue":"2","key":"2022022116204527400_B9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2215\/CJN.02070508","article-title":"Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis","volume":"4","author":"Changsirikulchai","year":"2009","journal-title":"Clin J Am Soc Nephrol."},{"issue":"1","key":"2022022116204527400_B10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/bmt.2008.419","article-title":"Clinicopathological manifestations and treatment of intestinal transplant-associated microangiopathy","volume":"44","author":"Inamoto","year":"2009","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"2022022116204527400_B11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood-2015-03-636753","article-title":"Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment","volume":"126","author":"McDonald","year":"2015","journal-title":"Blood."},{"issue":"2","key":"2022022116204527400_B12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2165\/00003495-200969020-00004","article-title":"Thrombotic microangiopathy in haematopoietic stem cell transplantation: diagnosis and treatment [review]","volume":"69","author":"Choi","year":"2009","journal-title":"Drugs."},{"issue":"1","key":"2022022116204527400_B13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3324\/haematol.10699","article-title":"Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group","volume":"92","author":"Ruutu","year":"2007","journal-title":"Haematologica."},{"issue":"8","key":"2022022116204527400_B14","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","article-title":"Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation","volume":"11","author":"Ho","year":"2005","journal-title":"Biol Blood Marrow Transplant."},{"issue":"9","key":"2022022116204527400_B15","first-page":"565","article-title":"Hematopoietic transplant-associated thrombotic microangiopathy: case report and review of diagnosis and treatments","volume":"12","author":"Chapin","year":"2014","journal-title":"Clin Adv Hematol Oncol."},{"issue":"10","key":"2022022116204527400_B16","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/bmt.2017.39","article-title":"Transplant-associated thrombotic microangiopathy: opening Pandora\u2019s box","volume":"52","author":"Gavriilaki","year":"2017","journal-title":"Bone Marrow Transplant."},{"issue":"8","key":"2022022116204527400_B17","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.bmt.1705758","article-title":"Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?","volume":"40","author":"Batts","year":"2007","journal-title":"Bone Marrow Transplant."},{"issue":"7","key":"2022022116204527400_B18","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.bbmt.2005.04.007","article-title":"Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Cutler","year":"2005","journal-title":"Biol Blood Marrow Transplant."},{"issue":"5","key":"2022022116204527400_B19","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.bbmt.2018.01.009","article-title":"Early increase in complement terminal pathway activation marker sC5b-9 is predictive for the development of thrombotic microangiopathy after stem cell transplantation","volume":"24","author":"Horvath","year":"2018","journal-title":"Biol Blood Marrow Transplant."},{"issue":"11","key":"2022022116204527400_B20","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00277-017-3092-9","article-title":"Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation","volume":"96","author":"Qi","year":"2017","journal-title":"Ann Hematol."},{"issue":"2","key":"2022022116204527400_B21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1182\/blood-2008-07-167098","article-title":"A biomarker panel for acute graft-versus-host disease","volume":"113","author":"Paczesny","year":"2009","journal-title":"Blood."},{"issue":"1","key":"2022022116204527400_B22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/bmt.2017.236","article-title":"Donor and recipient plasma follistatin levels are associated with acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402","volume":"53","author":"Turcotte","year":"2018","journal-title":"Bone Marrow Transplant."},{"issue":"8","key":"2022022116204527400_B23","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","article-title":"Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation","volume":"90","author":"Cho","year":"2010","journal-title":"Transplantation."},{"issue":"12","key":"2022022116204527400_B24","first-page":"1189","volume":"376"},{"issue":"6","key":"2022022116204527400_B25","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/bjh.16457","article-title":"Incidence, risk factors for and outcomes of transplant-associated thrombotic microangiopathy","volume":"189","author":"Epperla","year":"2020","journal-title":"Br J Haematol."},{"issue":"3","key":"2022022116204527400_B26","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.bbmt.2018.10.015","article-title":"Transplant-associated thrombotic microangiopathy is a multifactorial disease unresponsive to immunosuppressant withdrawal","volume":"25","author":"Li","year":"2019","journal-title":"Biol Blood Marrow Transplant."},{"issue":"5","key":"2022022116204527400_B27","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3324\/haematol.2019.233478","article-title":"Endothelial injury, F-actin and vitamin-D binding protein after hematopoietic stem cell transplant and association with clinical outcomes","volume":"106","author":"Luebbering","year":"2020","journal-title":"Haematologica."},{"issue":"2","key":"2022022116204527400_B28","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/bmt.2015.261","article-title":"A risk-adapted approach to acute GVHD treatment: are we there yet?","volume":"51","author":"Holtan","year":"2016","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"2022022116204527400_B29","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMoa1213299","article-title":"ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death","volume":"369","author":"Vander Lugt","year":"2013","journal-title":"N Engl J Med."},{"issue":"2","key":"2022022116204527400_B30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.pharmthera.2011.10.004","article-title":"Age-related changes in endothelial function and blood flow regulation","volume":"133","author":"Toda","year":"2012","journal-title":"Pharmacol Ther."},{"issue":"9","key":"2022022116204527400_B31","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1042\/CS20100476","article-title":"Aging and vascular endothelial function in humans","volume":"120","author":"Seals","year":"2011","journal-title":"Clin Sci (Lond)."},{"issue":"9","key":"2022022116204527400_B32","doi-asserted-by":"crossref","first-page":"E234","DOI":"10.1002\/ajh.25551","article-title":"Biopsy-proven thrombotic microangiopathy without schistocytosis on peripheral blood smear: a cautionary tale","volume":"94","author":"Murphree","year":"2019","journal-title":"Am J Hematol."},{"key":"2022022116204527400_B33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1182\/blood-2020-137752","article-title":"Thrombotic microangiopathy increases the risk of chronic kidney disease but not overall mortality in long-term survivors [abstract]","volume":"136","author":"Ang Li","year":"2020","journal-title":"Blood."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/4\/1342\/1873630\/advancesadv2021004933.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/4\/1342\/1873630\/advancesadv2021004933.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T16:30:32Z","timestamp":1645461032000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/4\/1342\/483217\/Acute-GVHD-BK-virus-hemorrhagic-cystitis-and-age"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,21]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,2,22]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021004933","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,21]]}}}